{
  "id": "5e17c97f6594cbea",
  "title": "Berotralstat Becomes First Oral Prophylactic for Pediatric Patients With Hereditary Angioedema",
  "description": "20251218T000000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/berotralstat-becomes-first-oral-prophylactic-for-pediatric-patients-with-hereditary-angioedema",
  "published_at": "20251218T000000Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/berotralstat-becomes-first-oral-prophylactic-for-pediatric-patients-with-hereditary-angioedema",
    "url_mobile": "",
    "title": "Berotralstat Becomes First Oral Prophylactic for Pediatric Patients With Hereditary Angioedema",
    "seendate": "20251218T000000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/c4812e2e04c97c1f4b043a103677fc0e51b1f0e3-5760x3840.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}